Avita Therapeutics

$5.69 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Avita Therapeutics

AVITA Medical Inc., formerly AVITA Therapeutics, Inc., is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. Its technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. It has developed RECELL System, a product for the treatment of acute thermal burn injuries in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patient’s own skin, providing a way to treat severe burns that significantly reduces the amount of donor skin required. It can be used at the point of care alone or in combination with split-thickness skin autografts depending on the depth of the burn injury.

Stock Analysis

last close $5.69
1-mo return -11.6%
3-mo return -37%
avg daily vol. 127.39T
52-week high 22.49
52-week low 5.06
market cap. $139M
forward pe -
annual div. -
roe -32.5%
ltg forecast -
dividend yield -
annual rev. $28M
inst own. 34.1%

Subscribe now for daily local and international financial news